arrow
Back
P

Parambir S. Dulai

northwestern university

58H-index
550Paper Count
1.5WCitation Count
Published Papers 251
Publication Date
Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy
err2026-09-23
err0
PREAI
errNikhit Kethidi; Saumya Pothukuchi; Adolfo Aleman; Daniel Charytonowicz; Christina Kuhn; Thomas Wong; Jennifer Claytor; Pablo Canales-Herrerias; Samane Khoshbakht; Akanksha Acharya; Michael Tankelevich; Tin Htwe Thin; Divya Jha; Matthias Ceulemans; Alexandra E. Livanos; Catherine Le Berre; Zachary M. Avigan; Luise Fischer; Jacqueline E. Birkness-Gartman; Joanna Melia; Yimei Jin; Rachel Chen; Isha Parikh; Meenakshi Mehrotra; Erika Patel; Shriya Desai; Sidorela Reci; Kedwin Ventura; Rudra Prasad Dutta; Benjamin Gordon; Rachel Brody; Charlotte Cunningham-Rundles; Zhihong Chen; Seunghee Kim-Schulze; Parambir S. Dulai; Shruti Naik; Jane Houldsworth; Maximilian Merz; Randy S. Longman; Ivan Zanoni; Jeremiah Faith; Jean-Frederic Colombel; Britta Siegmund; Raja Atreya; Markus F. Neurath; Shambavi Richard; Sundar Jagannath; Jerome C. Martin; Eric Meffre; Mayte Suarez-Farinas; David Muniz Pedrogo; Alexandros D. Polydorides; Samir Parekh; Saurabh Mehandru
errShare
errSave
Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia
err2026-08-21
err0
errOAAI
errRosane M. B. Teles; Chaouki Benabdessalem; Jonathan Perrie; Cenfu Wei; Julie West; Bruno J. de Andrade Silva; Priscila R. Andrade; Lilah A. Mansky; Prajan Divaka; Linda Fischbacher; Karen Lam; Feiyang Ma; Yiqian Gu; Kimia Rategh; Madeline Brown; Aparna Pillai; Kapongo Lumamba; Threnesan Naidoo; Samuel M. French; Emna Romdhane; Mohamed-Ridha Barbouche; Eynav Klechevsky; Marco Colonna; Adrie J. C. Steyn; Steven J. Bensinger; Daniel L. Barber; Soumaya Rammeh; Parambir S. Dulai; Bryan D. Bryson; Matteo Pellegrini; John T. Belisle; Barry R. Bloom; Robert L. Modlin
errShare
errSave
Butyrate epigenetically licenses sustained epithelial-T cell crosstalk for intestinal immune tolerance
err2026-07-15
err0
errOAAI
errTianming Yu; Wenjing Yang; Anthony J. Bilotta; Suxia Yao; Jeong-Heon Lee; Qihong Zhao; Jia Zhou; Tamas Ordog; Parambir S. Dulai; Yingzi Cong
errShare
errSave
A decade of clinical data with vedolizumab: the past, present, and future
err2026-05-25
err0
PREAI
errVipul Jairath; Alessandro Armuzzi; Christian Agboton; Brian Bressler; Silvio Danese; Parambir S. Dulai; Marlies Meyer; Itzel Romo Bautista; Raja Atreya; Brian G. Feagan
errShare
errSave
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn’s disease
err2026-05-04
err0
PREAI
errParambir S. Dulai; Giorgos Bamias; Vipul Jairath; Anthony Buisson; Marlies Meyer; Dirk Lindner; Christian Agboton; Laurent Peyrin-Biroulet
errShare
errSave
errShare
errSave
Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials
err2026-04-28
err0
errOAAI
errYiming Li; Cenfu Wei; Wenjing Yang; Hai Wang; Alan Robinson; Isabella Peshek; Tianming Yu; Jiwoon Park; Jenny Yanyi Ding; Stephen B. Hanauer; Emanuelle Bellaguarda; Laura Yun; Ronen Sumagin; Guang-Yu Yang; Christopher E. Mason; James D. Lewis; Deyu Fang; Yingzi Cong; Yuan Luo; Parambir S. Dulai
errShare
errSave
Geometrically Encoded Positioning of Introns, Intergenic Segments, and Exons in the Human Genome (Adv. Sci. 6/2026)
err2026-01-31
err0
errOAAI
errLuay M. Almassalha; Kyle L. MacQuarrie; Marcelo Carignano; Cody L. Dunton; Ruyi Gong; Joe Ibarra; Lucas M. Carter; Wing Shun Li; Rikkert Nap; Parambir S. Dulai; Igal Szleifer; Vadim Backman
errShare
errSave
Safety of Janus kinase inhibitors compared to biologic therapy in patients with inflammatory bowel disease
err2026-01-01
err0
PREAI
errKochhar, Gursimran S.; Khataniar, Himsikhar; Dulai, Parambir S.; Desai, Aakash
errShare
errSave
Impact of prior inadequate response to advanced therapies on early symptomatic improvement with obefazimod induction in moderately to severely active ulcerative colitis: results from the two Phase 3 placebo-controlled ABTECT induction trials
err2026-01-01
err0
PREAI
errAtreya, R.; Sands, B. E.; Rubin, D. T.; Dubinsky, M. C.; Armuzzi, A.; Treton, X.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Hlavaty, T.; Witek, R.; Dulai, P.; Danese, S.
errShare
errSave
Pooled analysis of efficacy and safety of once-daily oral obefazimod in North American patients from the ABTECT Phase 3, double-blind, placebo-controlled induction trials
err2026-01-01
err0
PREAI
errSands, B. E.; Dubinsky, M. C.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Panaccione, R.; Ritter, T. E.; Siddiqui, J.; Duvall, G. A.; Dulai, P.
errShare
errSave
Impact of baseline disease extent on efficacy of obefazimod in patients with moderately to severely active ulcerative colitis: pooled results from ABTECT-1 and ABTECT-2 phase 3 trials
err2026-01-01
err0
PREAI
errHeeren, S.; Dulai, P.; Neneman, B.; Bunganic, B.; Pumprla, J.; Cataldi, F.; Jacobstein, D.; Rabbat, C.; Shan, K.; Peyrin-Biroulet, L.
errShare
errSave
Obefazimod induction therapy for moderately to severely active ulcerative colitis: pooled analysis of inflammatory biomarkers from the two ABTECT Phase 3 double-blind, placebo-controlled induction trials
err2026-01-01
err0
PREAI
errSiegmund, B.; Atreya, R.; Cataldi, F.; Jacobstein, D.; Santo, J.; Rabbat, C.; Shan, K.; Miheller, P.; Gilletta De Saint Joseph, C.; Wojnarska, B. G.; Verstockt, B.; Magro, F.; Dulai, P.
errShare
errSave
Unsupervised Machine Learning to Identify Distinct Response Patterns to Guselkumab in Participants With Crohn's Disease: Post Hoc Analysis of the Pooled GRAVITI and GALAXI 2/3 Studies
err2025-12-01
err0
PREAI
errDulai, Parambir S.; D'haens, Geert; Reinisch, Walter; Hart, Ailsa; Rani, Sudheer; Olurinde, Mobolaji; Van Rampelbergh, Rian; Gao, Long-Long; Yang, Zijiang; Hoops, Timothy; Valiathan, Chandni; Schreiber, Stefan
errShare
errSave
Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)
err2025-12-01
err0
PREAI
errSands, Bruce E.; Danese, Silvio; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Hisamatsu, Tadakazu; Tilg, Herbert; Atreya, Raja; Armuzzi, Alessandro; Treton, Xavier; Baert, Filip; Seidler, Ursula; Cataldi, Fabio; Jacobstein, Doug; Rabbat, Christopher J.; Shan, Kejia; Duvall, George Aaron; Siegmund, Britta; Dulai, Parambir S.; Rubin, David; Vermeire, Severine
errShare
errSave
errShare
errSave
Serum and Histologic Eosinophilia as a Predictive Biomarker of Response to Mirikizumab in Ulcerative Colitis
err2025-11-01
err0
PREAI
errWong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Jairath, Vipul; Reinisch, Walter; Narula, Neeraj
errShare
errSave
Geometrically Encoded Positioning of Introns, Intergenic Segments, and Exons in the Human Genome
err2025-10-27
err0
errOAAI
errLuay M. Almassalha; Kyle L. MacQuarrie; Marcelo Carignano; Cody L. Dunton; Ruyi Gong; Joe Ibarra; Lucas M. Carter; Wing Shun Li; Rikkert Nap; Parambir S. Dulai; Igal Szleifer; Vadim Backman
errShare
errSave
A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice
err2025-10-01
err0
PREAI
errHuan, Peter W.; Mehta, Akash; Wong, Emily C. L.; Dulai, Parambir S.; Marshall, John K.; Reinisch, Walter; Narula, Neeraj
errShare
errSave